Poseida Therapeutics, Inc.

New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Dec 24, 2015
Total Offering

$36,033,230

Amount Sold

$23,033,232

Investors

14

First Sale

Dec 15, 2015

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Nishan de Silva
Related Person
Eric Ostertag
Related Person
Lars Ekman
Related Person

Company

Poseida Therapeutics, Inc.

4250 EXECUTIVE SQUARE, SUITE 900

LA JOLLA, CA, 92037

858-242-1576

SEC Filing

0001661460-15-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free